Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Schulz

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Neuroscience Letters|May 13, 1999
Differential effects of L-buthionine sulfoximine and ethacrynic acid on glutathione levels and mitochondrial function in PC12 cellsJ Seyfried, F Soldner, J B Schulz, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 1, 1995
Improved therapeutic window for treatment of histotoxic hypoxia with a free radical spin trapJ B Schulz, R T Matthews, B G Jenkins, et al.
The European Journal of Neuroscience|October 18, 2006
Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat modelS Breit, L Lessmann, D Unterbrink, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Developmental and genetic regulation of programmed neuronal deathM Weller, J B Schulz, U Wüllner, et al.
Acta Neuropathologica|October 1, 1998
Bcl-2, Bax and Bcl-x expression in neuronal apoptosis: a study of mutant weaver and lurcher miceU Wüllner, M Weller, J B Schulz, et al.
Der Nervenarzt|September 4, 2015
[Amyloid β-related angiitis as rare cause of a generalized convulsive seizure]L S König, M Wiesmann, R Pjontek, et al.
Fortschritte Der Neurologie-Psychiatrie|March 3, 2010
[On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease]J Kassubek, T Büttner, H Reichmann, et al.
Molecular and Cellular Neurosciences|February 13, 2001
Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectorsS Kügler, L Meyn, H Holzmüller, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Altered expression of calcium- and apoptosis-regulating proteins in multiple system atrophy Purkinje cellsU Wüllner, M Weller, J Kornhuber, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2001
Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's diseaseX G Xia, T Harding, M Weller, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Neuroscience Letters|May 13, 1999
Differential effects of L-buthionine sulfoximine and ethacrynic acid on glutathione levels and mitochondrial function in PC12 cellsJ Seyfried, F Soldner, J B Schulz, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 1, 1995
Improved therapeutic window for treatment of histotoxic hypoxia with a free radical spin trapJ B Schulz, R T Matthews, B G Jenkins, et al.
The European Journal of Neuroscience|October 18, 2006
Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat modelS Breit, L Lessmann, D Unterbrink, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Developmental and genetic regulation of programmed neuronal deathM Weller, J B Schulz, U Wüllner, et al.
Acta Neuropathologica|October 1, 1998
Bcl-2, Bax and Bcl-x expression in neuronal apoptosis: a study of mutant weaver and lurcher miceU Wüllner, M Weller, J B Schulz, et al.
Der Nervenarzt|September 4, 2015
[Amyloid β-related angiitis as rare cause of a generalized convulsive seizure]L S König, M Wiesmann, R Pjontek, et al.
Fortschritte Der Neurologie-Psychiatrie|March 3, 2010
[On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease]J Kassubek, T Büttner, H Reichmann, et al.
Molecular and Cellular Neurosciences|February 13, 2001
Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectorsS Kügler, L Meyn, H Holzmüller, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Altered expression of calcium- and apoptosis-regulating proteins in multiple system atrophy Purkinje cellsU Wüllner, M Weller, J Kornhuber, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2001
Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's diseaseX G Xia, T Harding, M Weller, et al.
Pageof 13